Skip to main content
. 2018 Dec 1;141(1):83–94. doi: 10.1007/s11060-018-03005-x

Table 2.

Patients characteristics and follow-up data

Patient Age, sex Recurrence MGMT methylation Treatment NP removal PFS (months) OS (months) Status
1 42, f 1 1 NT + RX 1 29.1 29.1 0
2 59, m 1 0 NT + RX 1 10.6 23.9 1
3 75, f 1 0 NT 1 5.3 7.1 1
4 60, m 2 0 NT + RX 0 6.9 7.1 1
5 65, m 2 1 NT + RX 1 5.6 9.2 1
6 42, m 4 0 NT 0 2.8 3.7 1

NP nanoparticle, NT nanotherapy, RT radiotherapy, 0 alive, 1 dead

Last update 14 May 2018